PDRN in Skincare: What Is It and How Does It Work?
PDRN, short for polydeoxyribonucleotide, is a DNA-derived material that has been investigated for many years in regenerative medicine and tissue repair. More recently, it has gained significant attention in the cosmetic industry, particularly in Korean skincare, where it is used in serums, creams, masks and other skin-rejuvenating formulations.
Its growing popularity is not entirely based on marketing. Research has identified several interesting biological mechanisms associated with PDRN, including activation of the adenosine A2A receptor, modulation of inflammatory pathways and involvement in nucleotide salvage pathways.
However, there is an important distinction that is sometimes overlooked:
Evidence for PDRN in medical or injectable applications should not automatically be interpreted as evidence for the same effect from a topical cosmetic product.
Understanding this distinction is essential when developing or evaluating a PDRN-based skincare product.
What Is PDRN?
PDRN stands for polydeoxyribonucleotide and refers to purified DNA fragments composed of deoxyribonucleotide chains.
PDRN used in biomedical research has traditionally been obtained from highly purified DNA sources, particularly salmon trout (Oncorhynchus mykiss) and chum salmon (Oncorhynchus keta). Published reviews describe PDRN materials with molecular weights broadly ranging from approximately 50 to 1,500 kDa, depending on the material and preparation.
Unlike a conventional small-molecule cosmetic active, PDRN is therefore a relatively large biological material.
Its biological interest comes not simply from the fact that it is "DNA", but from what happens to the DNA fragments and their breakdown products in biological systems.
This is also why the term "salmon DNA" is often used in consumer-facing skincare marketing, although this expression does not adequately describe the chemistry or biological activity of the material.
How Does PDRN Work?
One of the best-described mechanisms associated with PDRN is its interaction with the adenosine A2A receptor pathway.
Adenosine receptors are involved in numerous physiological processes, including inflammation, vascular responses and tissue repair. Research has suggested that PDRN can stimulate A2A receptor signalling, which can influence inflammatory processes and cellular responses associated with tissue regeneration.
The A2A receptor pathway
Activation of the A2A receptor can influence signalling pathways involved in inflammation and tissue recovery.
Research reviewed in the literature has associated PDRN with:
- modulation of inflammatory cytokines,
- reduced inflammatory signalling,
- effects on apoptosis,
- promotion of angiogenesis,
- increased cellular activity,
- and stimulation of processes associated with tissue repair.
The 2023 review provided as a reference for this article is particularly interesting in this context. Although its primary focus is particulate-matter-induced cellular damage and apoptosis, it discusses PDRN as one of the potential therapeutic approaches for modulating apoptosis and inflammatory responses.
This is an important example of how PDRN's biological activity extends beyond the cosmetic industry.
PDRN and the Nucleotide Salvage Pathway
Another proposed mechanism is the nucleotide salvage pathway.
Cells require nucleotides for processes such as DNA and RNA synthesis and cellular proliferation. Rather than synthesising all nucleotides from scratch, cells can recycle nucleotide components through salvage pathways.
PDRN has been associated with this process, providing nucleotide-related substrates that can be reutilised by cells.
Together, the A2A receptor pathway and nucleotide salvage pathway help explain why PDRN has attracted attention in regenerative medicine.
However, the presence of a plausible biological mechanism does not by itself establish the clinical efficacy of a particular cosmetic formulation.
That distinction is particularly important when moving from injection or medical application to topical skincare.
What Are the Potential Benefits of PDRN for Skin?
Research into PDRN has identified several areas of potential interest for dermatology and skin science.
1. Supporting tissue repair
PDRN has been extensively investigated in the context of wound healing and tissue regeneration.
Studies have associated PDRN treatment with processes involved in tissue repair, including cellular activity, angiogenesis and extracellular matrix formation.
This is one of the reasons PDRN became established in regenerative medicine before becoming a major skincare trend.
2. Modulating inflammation
Inflammation is an important component of many skin conditions and of the skin-aging process.
PDRN's interaction with the A2A receptor has been associated with modulation of inflammatory signalling and reduction of pro-inflammatory responses.
This makes PDRN particularly interesting for formulations positioned around skin recovery and skin comfort.
3. Supporting collagen-related processes
Some research has reported increased collagen synthesis following PDRN treatment.
A 2022 review of PDRN's potential anti-aging applications describes research linking PDRN with fibroblast activity, collagen synthesis and inhibition of mechanisms associated with collagen degradation.
However, it is important not to translate these findings directly into a claim that every topical PDRN serum will increase collagen production in human skin.
The formulation, dose, delivery route and bioavailability all matter.
4. Skin revitalisation and appearance
Because of its potential effects on cellular activity, inflammation and tissue regeneration, PDRN has been investigated as a skin-rejuvenating ingredient.
The published literature describes potential benefits related to skin texture, pigmentation, elasticity and overall skin quality.
Again, the strongest evidence should not be confused with evidence for conventional topical cosmetic use.
PDRN and Skin Aging
Skin aging is influenced by both intrinsic biological aging and external factors such as UV exposure and environmental stress.
At the molecular level, oxidative stress can contribute to activation of pathways such as MAPK and NF-κB, increased inflammatory signalling and matrix metalloproteinase activity, while reducing pathways involved in collagen synthesis.
The PDRN literature proposes that A2A receptor activation can influence some of these processes, including inflammatory signalling and mechanisms associated with collagen degradation.
This provides a scientifically interesting rationale for investigating PDRN in anti-aging skincare.
But there is a major difference between:
"PDRN has biological mechanisms that may be relevant to skin aging"
and:
"A topical PDRN cream reverses skin aging."
The first statement is supported by the scientific literature. The second requires product-specific clinical evidence.
PDRN vs. Polynucleotides: Are They the Same?
This is one of the most confusing aspects of the current skincare market.
PDRN and PN (polynucleotides) are related, but they should not automatically be treated as identical materials.
PDRN generally refers to relatively shorter DNA fragments, whereas polynucleotide materials used in aesthetic medicine can have different molecular characteristics and specifications.
The distinction becomes particularly important because many consumer articles use PDRN, PN, polynucleotide and "salmon DNA" almost interchangeably.
Recent literature has specifically highlighted the need to distinguish PDRN from PN based on their molecular characteristics, mechanisms and clinical applications.
For product developers, this is more than a terminology issue.
The source material, molecular-weight distribution, purification process, concentration and intended application should all be clearly defined before selecting an ingredient for a formulation.
What About PDRN in Topical Cosmetics?
This is where things become particularly interesting for formulators.
The skin is an exceptionally effective barrier. The stratum corneum limits the penetration of many substances applied to the skin, and molecular size, lipophilicity, formulation, skin condition and application conditions can all influence dermal absorption.
The dermatological formulation literature emphasises that the efficacy of a topical ingredient depends not only on the intrinsic activity of the molecule, but also on whether the formulation can deliver it to the relevant site in the skin.
Similarly, the Dermal Absorption and Toxicity Assessment reference describes dermal absorption as being influenced by factors including skin structure, permeant properties, formulation and method of application.
This creates an important question:
Can a relatively large PDRN molecule applied to the surface of the skin reach the biological targets responsible for the effects observed in medical studies?
The answer cannot simply be assumed to be yes.
This is one of the biggest areas where topical PDRN marketing can run ahead of the science.
Get the latest posts
Unlock a world of knowledge and inspiration - subscribe to our blog for exclusive content, expert insights, and exciting updates!
Formulation Matters
A PDRN raw material is not a finished skincare product.
When developing a PDRN formulation, the formulator needs to consider factors such as:
- molecular-weight distribution,
- raw-material purity,
- concentration of the active material,
- source and manufacturing process,
- pH,
- ionic environment,
- compatibility with other ingredients,
- preservation system,
- stability,
- packaging,
- and the intended delivery system.
The formulation itself can influence the physical and chemical environment surrounding the active ingredient.
This principle applies to PDRN just as it does to other sophisticated cosmetic actives: the ingredient and the delivery system need to be considered together.
The literature on cosmetic science has long emphasised that the vehicle is crucial in determining whether an active ingredient can be delivered effectively to its intended target.
What Is the INCI Name for PDRN?
In cosmetic products, PDRN-related materials may appear under names such as Sodium DNA, depending on the specific raw material and regulatory nomenclature.
However, it is important not to assume that every ingredient marketed commercially as "PDRN" has identical composition, molecular characteristics or origin.
For a formulation project, the raw-material documentation should therefore be reviewed carefully rather than relying solely on the marketing name.
A professional formulation assessment should consider documentation such as:
- INCI identity,
- specification,
- molecular-weight information,
- purity,
- microbiological quality,
- heavy metals where relevant,
- residual impurities,
- source,
- manufacturing process,
- stability information,
- recommended use level,
- and supplier safety documentation.
This is particularly important when developing a product for international markets.
Is Topical PDRN as Effective as Injectable PDRN?
We should not assume that it is.
This is probably the most important point for consumers and product developers.
Much of the published evidence for PDRN's regenerative effects comes from medical, experimental or injectable applications, rather than from conventional leave-on cosmetic products.
A 2022 review concluded that PDRN has promising anti-aging potential, while also noting that further research is required to fully establish its benefits.
More recent discussions of PDRN in skincare have likewise highlighted the difference between the evidence supporting medical applications and the still-developing evidence base for topical products.
The distinction is logical from a formulation perspective.
An injected material is delivered beyond the outermost skin barrier. A topical serum must first interact with—and potentially cross—the stratum corneum.
Therefore:
Injectable PDRN research ≠ proof of topical cosmetic efficacy.
This does not mean topical PDRN is ineffective. It means that the efficacy of a specific topical formulation needs to be demonstrated separately.
What Should Formulators Consider When Developing a PDRN Product?
For cosmetic product developers, PDRN presents an interesting formulation opportunity—but it should be approached as a technically challenging active rather than simply a trending ingredient.
1. Start with the raw material
Not all PDRN materials are necessarily equivalent.
The molecular-weight profile, purity, source and manufacturing process should be clearly documented.
2. Define the intended cosmetic benefit
Rather than starting with a broad claim such as "skin regeneration", the product concept should identify a realistic cosmetic benefit.
For example:
- skin conditioning,
- hydration,
- improved skin appearance,
- skin comfort,
- revitalised appearance,
- smoother-looking skin.
The appropriate claim strategy should then be supported by suitable efficacy testing.
3. Develop the formulation around the active
PDRN should not simply be added to a standard serum base.
The formulation should be designed around the raw material's characteristics, including its stability and compatibility with the rest of the formula.
4. Consider delivery
If the intended biological mechanism requires access to deeper skin layers, the delivery question becomes critical.
A formulator should evaluate whether the intended effect is realistically achievable through the proposed route of administration.
5. Generate product-specific evidence
This is perhaps the most important step.
Scientific literature can support the rationale for using PDRN, but it does not automatically substantiate the claims of a particular finished product.
A well-developed PDRN cosmetic should therefore be supported by appropriate testing of the actual formulation.
The Future of PDRN in Skincare
PDRN sits at an interesting intersection between cosmetic science, regenerative medicine and advanced skin-care formulation.
Its biological mechanisms are sufficiently interesting to justify continued research, while its popularity has created a rapidly expanding market for topical products.
The scientific literature supports the idea that PDRN can influence biological processes relevant to tissue repair, inflammation and cellular activity.
At the same time, the evidence base for topical cosmetic applications is not yet equivalent to the evidence accumulated in medical and experimental settings.
That makes PDRN neither simply a "miracle ingredient" nor merely a marketing trend.
It is a scientifically interesting active whose final performance depends on the material, the formulation, the delivery route and the evidence generated for the finished product.
For cosmetic brands considering a PDRN-based product, this distinction is crucial.
Conclusion
PDRN—or polydeoxyribonucleotide—is one of the more intriguing emerging ingredients in modern skincare.
Research has associated PDRN with mechanisms involving adenosine A2A receptor activation, inflammatory regulation, nucleotide salvage, cellular activity, tissue repair and collagen-related processes.
These properties provide a compelling scientific rationale for its use in skin-rejuvenation concepts.
However, the route of administration matters.
The biological effects demonstrated in medical and injectable applications cannot simply be transferred to a topical cosmetic product. The skin barrier, molecular characteristics of the ingredient and the design of the formulation all play important roles in determining what can actually happen after topical application.
For formulators and cosmetic brands, the real opportunity is therefore not simply to put "PDRN" on a product label.
It is to develop a well-characterised raw material, an appropriate delivery system, a stable formulation and scientifically substantiated cosmetic claims.
That is where PDRN moves from a skincare trend to a genuine formulation opportunity.
References
- Aghaei-Zarch SM et al. The impact of particulate matters on apoptosis in various organs: Mechanistic and therapeutic perspectives. Biomedicine & Pharmacotherapy. 2023;165:115054. DOI: 10.1016/j.biopha.2023.115054. ScienceDirect – original article
- Khan A, Wang G, Zhou F, et al. Polydeoxyribonucleotide: A promising skin anti-aging agent. Chinese Journal of Plastic and Reconstructive Surgery. 2022;4(4):187–193. DOI: 10.1016/j.cjprs.2022.09.015. ScienceDirect – review article
- Roberts MS, Walters KA, eds. Dermatologic, Cosmeceutic, and Cosmetic Development: Therapeutic and Novel Approaches. Informa Healthcare, 2008.
- Roberts MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment. 2nd ed. Informa Healthcare, 2008.
- Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives. Pharmaceutics. 2025.
Related posts
How Long Does It Take to Make Your Own Cosmetic Product?
